Clinical Proteomics

Papers
(The median citation count of Clinical Proteomics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets40
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins33
Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature25
Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies24
Many kinds of oxidized proteins are present more in the urine of the elderly19
Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers19
13C15N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans18
The use of proteomics for blood biomarker research in premature infants: a scoping review16
Redefining serological diagnostics with immunoaffinity proteomics16
Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy15
Development of an ID-LC–MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum15
Label-free LC–MS/MS proteomics analyses reveal proteomic changes in oxidative stress and the SOD antioxidant strategy in TM cells14
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury13
Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders13
Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers12
Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line12
Changes of serum IgG glycosylation patterns in rheumatoid arthritis12
Kinase inhibitor pulldown assay (KiP) for clinical proteomics12
sBioSITe enables sensitive identification of the cell surface proteome through direct enrichment of biotinylated peptides11
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma11
Systematic evaluation and optimization of protein extraction parameters in diagnostic FFPE specimens11
Serum proteomics of severe fever with thrombocytopenia syndrome patients11
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers10
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers10
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables10
Change of histone H3 lysine 14 acetylation stoichiometry in human monocyte derived macrophages as determined by MS-based absolute targeted quantitative proteomic approach: HIV infection and methamphet10
Recent progress in mass spectrometry-based urinary proteomics10
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response9
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals8
Characterizing age-related changes in intact mitochondrial proteoforms in murine hearts using quantitative top-down proteomics8
Changes in amino acid concentrations and the gut microbiota composition are implicated in the mucosal healing of ulcerative colitis and can be used as noninvasive diagnostic biomarkers7
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients7
The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study7
Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry7
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics7
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer6
Using established biorepositories for emerging research questions: a feasibility study6
Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis6
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection6
Comment on “Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics”6
Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides6
Maternal serum CFHR4 protein as a potential non-invasive marker of ventricular septal defects in offspring: evidence from a comparative proteomics study6
Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat6
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors6
Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka5
Combination of automated sample preparation and micro-flow LC–MS for high-throughput plasma proteomics5
Resistin as a potential diagnostic biomarker for sepsis: insights from DIA and ELISA analyses5
Quantitative proteomics analysis of lysine 2-hydroxyisobutyrylation in IgA nephropathy5
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?5
Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma5
Proteomic analysis of decidua in patients with recurrent pregnancy loss (RPL) reveals mitochondrial oxidative stress dysfunction5
Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics5
Optimized data-independent acquisition approach for proteomic analysis at single-cell level5
Associations of circulating proteins with lipoprotein profiles: proteomic analyses from the OmniHeart randomized trial and the Atherosclerosis Risk in Communities (ARIC) Study5
A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples5
Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy5
Circulating proteins as predictive and prognostic biomarkers in breast cancer4
Decreased histidine-rich glycoprotein and increased complement C4-B protein levels in follicular fluid predict the IVF outcomes of recurrent spontaneous abortion4
Proteomic analysis of 92 circulating proteins and their effects in cardiometabolic diseases4
Validation of ANG-1 and P-SEL as biomarkers of post-COVID-19 conditions using data from the Biobanque québécoise de la COVID-19 (BQC-19)4
Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation4
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay4
Proteomics of prostate cancer serum and plasma using low and high throughput approaches4
Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan4
Integrative omics reveals subtle molecular perturbations following ischemic conditioning in a porcine kidney transplant model4
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies3
Correction: Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients3
Integrating functional proteomics and next generation sequencing reveals potential therapeutic targets for Taiwanese breast cancer3
Comparison of early changes in tear film protein profiles after small incision lenticule extraction (SMILE) and femtosecond LASIK (FS-LASIK) surgery3
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling3
Proteomic profiling of end-stage COVID-19 lung biopsies3
CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds3
Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex3
Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease3
A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning3
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases3
Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals3
Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue3
Proteomics-based evaluation of the mechanism underlying vascular injury via DNA interstrand crosslinks, glutathione perturbation, mitogen-activated protein kinase, and Wnt and ErbB signaling pathways 3
A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors3
Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity3
Research biopsies in kidney transplantation: an evaluation of surgical techniques and optimal tissue mass allowing molecular and histological analyses2
Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation2
A novel non-invasive method allowing for discovery of pathologically relevant proteins from small airways2
Correction: Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry2
Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients2
Novel plasma protein biomarkers from critically ill sepsis patients2
Human tear film protein sampling using soft contact lenses2
Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization2
Identification of SARS-CoV-2 biomarkers in saliva by transcriptomic and proteomics analysis2
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers2
Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls2
Simultaneous targeted and discovery-driven clinical proteotyping using hybrid-PRM/DIA2
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach2
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling2
Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation2
Elevated level of multibranched complex glycan reveals an allergic tolerance status2
SPOT: spatial proteomics through on-site tissue-protein-labeling2
Quantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients2
The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips2
Comparison of intact protein and digested peptide techniques for high throughput proteotyping of ApoE2
Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay2
Serum proteomics for the identification of biomarkers to flag predilection of COVID19 patients to various organ morbidities2
Correction to: Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources2
Cord blood platelet-rich plasma: proteomics analysis for ophthalmic applications2
Identification of biomarkers of chronic kidney disease among kidney-derived proteins2
Discovery of novel glioma serum biomarkers by proximity extension assay2
iTRAQ-based quantitative proteomic analysis of thoracic aortas from adult rats born to preeclamptic dams2
Proteomic analysis of plasma exosomes in patients with metastatic colorectal cancer2
Development of a rapid and specific MALDI-TOF mass spectrometric assay for SARS-CoV-2 detection2
Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification2
Quantitative proteomics reveals the effect of Yigu decoction (YGD) on protein expression in bone tissue2
0.017419099807739